Stabilized Pharmaceutical Formulations Of Insulin Aspart

< Back

Stabilized Pharmaceutical Formulations Of Insulin Aspart

Abstract: Stabilized pharmaceutical formulations of insulin aspart are disclosed. In particular the application is directed to a pharmaceutical formulation comprising (a) insulin aspart; and (b) Zn(ll); and (e) optionally protamine; wherein the pharmaceutical formulation contains less than 0.17 mg/mL sodium chloride.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #

Filing Date

06 June 2016

Publication Number

35/2016

Publication Type

INA

Invention Field

PHARMACEUTICALS

Status

Email

Parent Application

Applicants

SANOFI

54 rue La Boétie F 75008 Paris

Inventors

1. BLEY Oliver

c/o Sanofi Aventis Deutschland GmbH 65926 Frankfurt am Main

2. LOOS Petra

c/o Sanofi Aventis Deutschland GmbH 65926 Frankfurt am Main

3. BIDLINGMAIER Bernd

c/o Sanofi Aventis Deutschland GmbH 65926 Frankfurt am Main

4. KAMM Walter

c/o Sanofi Aventis Deutschland GmbH 65926 Frankfurt am Main

5. BERCHTOLD Harald

c/o Sanofi Aventis Deutschland GmbH 65926 Frankfurt am Main

Specification

Documents

Application Documents

#	Name	Date
1	Form 5 [06-06-2016(online)].pdf	2016-06-06
2	Form 3 [06-06-2016(online)].pdf	2016-06-06
3	Form 1 [06-06-2016(online)].pdf	2016-06-06
4	Description(Complete) [06-06-2016(online)].pdf	2016-06-06
5	Other Patent Document [02-09-2016(online)].pdf	2016-09-02
6	Other Patent Document [02-12-2016(online)].pdf	2016-12-02
7	Form 3 [05-12-2016(online)].pdf	2016-12-05
8	201637019419-FORM 18 [05-01-2018(online)].pdf	2018-01-05
9	201637019419-FER.pdf	2019-05-30
10	201637019419-AbandonedLetter.pdf	2020-01-01

Search Strategy

1	SEARCHstrategy_30-05-2019.pdf